In contrast, the sensitivity of IFSH for predicting final surgical margin status was low, at 21.7%. This indicates that while ...

Five-year data shows lasting benefit for patients with advanced gastroesophageal cancers treated with nivolumab and chemotherapy.

Nearly half of patients with advanced ovarian cancer treated with first-line poly-ADP-ribose polymerase (PARP) inhibitors experienced recurrence in this real-world study, emphasizing the need for ...

Parents vaccinated against COVID-19 were almost twice as likely to vaccinate their child against measles, mumps and rubella compared with unvaccinated parents, according to a study published in ...

Nivolumab plus chemotherapy improved long-term survival in Chinese patients with advanced gastric, GEJ, or esophageal cancer.

The phase 3 CheckMate 649 trial showed that nivolumab plus chemotherapy significantly improved long-term overall survival in Chinese patients with advanced gastric, gastroesophageal junction, and ...

CheckMate 649 trial showed sustained efficacy with frontline nivolumab plus chemotherapy vs chemotherapy alone in patients with gastric cancers.

A study of nearly 1,000 people with post-COVID-19 syndrome (PCS) revealed that two-thirds still experienced significant symptoms, including reduced exercise capacity and cognitive performance, two ...

Friendswood ISD’s average daily attendance, or ADA, rose over the fall semester between 1%-2% in each campus compared to the 2023-24 school year, according to a Jan. 15 news release from the district.

A retrospective study demonstrated slightly elevated baseline fasting plasma glucose levels to be a robust marker of incident diabetes risk, even when those levels fell within the normal range.

Two major road projects in Bridgeland are expected to come to an end in the next few months. The details The extension of ...

FDA delays Stealth BioTherapeutics' elamipretide decision to April 29; Valneva's Ixchiq succeeds in child safety trial; TargetRx raises $50M; Ab&B Bio-Tech files for HKEX IPO ...